It does appear that Starpharma have a 3 stage process regarding partnerships and research agreements doesn’t it?
1) Talk up and highlight partnerships and research agreements in QRs and presentations
then
2) Only mention certain partnerships in footnotes and fine print of announcements
then
3) Partnership or research agreement never mentioned again
Cue next shiny toy ….
It does appear that Starpharma have a 3 stage process regarding...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $41.20M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.0¢ | 9.9¢ | $10.30K | 103.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 72122 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 416976 | 4 |
View Market Depth
| Last trade - 11.45am 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.5¢ |
Change
0.002 ( 6.49 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.5¢ | 10.0¢ | 42145 | ||
| Last updated 12.15pm 12/06/2024 ? | |||||
| SPL (ASX) Chart |